SJ Medical
SJ Medical
Explore our premium selection of advanced clinical products, diagnostic equipment, and surgical reconstruction scaffolds.
A comprehensive analysis of biological scaffolds, tissue reconstruction, clinical efficacy, and manufacturing standards in modern surgery.
In modern soft tissue repair and reconstruction, the surgical community has witnessed a massive transition from traditional synthetic meshes (such as polypropylene or polyester) to highly biocompatible biological mesh products. While synthetic meshes provide immediate mechanical support, they often trigger a chronic foreign body reaction, leading to complications like mesh erosion, chronic pain, and persistent infection. Biological meshes, particularly those derived from acellular dermal matrix (ADM) and collagen biological scaffolds, offer a natural extracellular matrix (ECM) that acts as a structural framework for cell infiltration, vascularization, and eventual tissue remodeling.
Biological mesh products allow the patient's own cells to populate the matrix, gradually replacing the scaffold with healthy, vascularized native tissue. This process of cellular remodeling significantly minimizes long-term infection risks, making biological meshes the gold standard in contaminated surgical sites, complex ventral hernia repairs, breast reconstructions, and pelvic organ prolapse treatments.
At the center of biological tissue engineering is the Hadm Long-Acting Collagen Biological Scaffold. Utilizing advanced decellularization processes, manufacturers extract collagen matrices from donor tissues while completely removing antigenic cellular components. This minimizes immunogenic responses in the host organism while preserving the vital collagen triple-helix structures.
The long-acting nature of these scaffolds is determined by controlled cross-linking densities. By applying specialized cross-linking agents and physical sterilization parameters, the in-vivo degradation rate is carefully balanced against the rate of neo-tissue formation. This ensures that the scaffold retains mechanical integrity and continues to load-share throughout the crucial healing phases, preventing early recurrence or tissue laxity.
Complete cellular extraction guarantees minimal immunological reaction, preventing rejection and promoting rapid integration into host tissues.
The intact extracellular matrix (ECM) promotes fast angiogenesis, feeding new cells and fighting bacterial colonization effectively.
Engineered degradation profiles ensure the scaffold provides structural support until the host tissue is fully mature.
China has emerged as a premier hub for biological mesh product manufacturing. Leveraging a combination of massive industrial infrastructure, high-end cleanroom systems, and significant cost efficiencies, Chinese factories supply global healthcare markets with top-tier biomedical devices. The major advantages of sourcing from Chinese biological mesh manufacturers include:
To market Class III medical devices such as biological scaffolds globally, adherence to strict compliance and localization programs is essential. Top manufacturers like Hangzhou SJ Medical Co., Ltd. align their operations with international regulations to facilitate smooth product registration, import procedures, and clinical uptake.
Our validation protocols comply fully with the requirements of major international markets:
Pioneering innovations in cardiovascular, peripheral vascular interventional devices, and advanced biomaterials.
Hangzhou SJ Medical Co., Ltd. was established in 2015 and is dedicated to the research, development, manufacturing, and commercialization of vascular interventional medical devices. The company focuses on both cardiovascular and peripheral intervention fields, striving to provide safe, reliable, and innovative solutions for healthcare providers worldwide.
Over the years, SJ Medical has developed a comprehensive product portfolio covering key areas of vascular intervention. Its offerings span from various types of balloon catheters for coronary and peripheral applications to supporting access and diagnostic devices, as well as advanced stent systems. Through continuous innovation and strong R&D capabilities, the company has obtained multiple patents and international certifications, laying a solid foundation for sustainable growth in both domestic and global markets.
SJ Medical operates a modern manufacturing facility with a total area of approximately 5,000 square meters. The factory is built in accordance with GMP standards and features a high-standard cleanroom environment, including a million-class clean workshop with localized hundred-class areas for critical processes.
The company is supported by a highly experienced technical team, many of whom have been engaged in the medical device industry for decades. Under the leadership of senior engineers, SJ Medical maintains strict quality control and continuously improves its manufacturing processes to ensure product reliability and consistency.
SJ Medical focuses on the development of vascular interventional devices designed for both coronary and peripheral procedures. Its product range integrates interventional access systems, diagnostic catheters, and therapeutic devices, forming a complete solution for minimally invasive vascular treatments. Each product is developed with an emphasis on precision, safety, and clinical performance, aiming to support physicians in achieving optimal procedural outcomes.
The company’s products are widely applied in minimally invasive procedures involving both coronary and peripheral vascular systems. They play an important role in the diagnosis and treatment of vascular diseases, helping to improve procedural efficiency while enhancing patient safety and recovery.
SJ Medical strictly adheres to international quality standards and regulatory requirements. The company has obtained CE certification, ISO 13485 quality management system certification, and CFDA approval, along with free sale certificates, demonstrating its strong commitment to product quality and compliance.
The company is equipped with advanced production and inspection systems, including precision balloon forming equipment, laser welding and marking technologies, and comprehensive laboratory testing facilities. These capabilities ensure high levels of manufacturing accuracy, product consistency, and full-process quality control.
SJ Medical has established long-term partnerships with clients across Europe, Asia, the Middle East, and Africa. Its products are currently distributed in countries such as Finland, Italy, Spain, France, the Netherlands, India, Indonesia, Turkey, and Egypt, among others. The company continues to expand its international footprint and strengthen its global presence.
SJ Medical is committed to providing comprehensive and professional services throughout the entire customer journey. From pre-sales consultation and technical support to efficient order processing and responsive after-sales service, the company ensures that every customer receives timely assistance and reliable solutions.
Analyzing key considerations for global medical B2B procurement managers and clinical advancements in regenerative tissue scaffolds.
Global procurement teams seek tailored solutions including specific mesh sizes, shapes, and degradation speeds to match regional surgical habits. Our factories support custom laser-cutting configurations and variable thickness matching.
Double-barrier sterile packaging alongside validated shelf-life testing is vital. We utilize advanced physical sterilization systems to maintain the fragile molecular matrix of the collagen while guaranteeing 10-6 Sterility Assurance Level (SAL).
Unlike standard synthetic devices, natural biological scaffolds often require specific temperature and moisture storage. China's highly developed cold chain logistics support door-to-door delivery with live temp logging.
The latest developmental trend highlights biological scaffolds integrated with lightweight synthetic fibers. This hybrid solution offers immediate high tensile strength while retaining excellent long-term remodeling advantages.
Beyond traditional hernia repairs, biological meshes are finding use in deep reconstructive procedures, plastic surgeries, gynecological support, and peripheral nerve wrapping.
By optimizing cellular extraction protocols and capitalizing on China's massive industrial clusters, our factories supply premium biomaterials at competitive costs, enhancing global patient accessibility.
Crucial information regarding compliance, procurement, material science, and custom biological scaffold manufacturing.
Browse our integrated vascular intervention solutions, API raw materials, and clinical accessories.
